Stock Earnings

Question 1

Unicycive Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Unicycive Therapeutics Inc'in toplam varlıkları $31 olup, net loss $-37'dir.

Question 2

UNCY'ün temel finansal oranları nelerdir?

Accepted Answer

Unicycive Therapeutics Inc'in cari oranı 1.29, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Unicycive Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Unicycive Therapeutics Inc largest revenue segment is Novel Therapies, at a revenue of 675,000 in the most earnings release.For geography, United States is the primary market for Unicycive Therapeutics Inc, at a revenue of 675,000.

Question 4

Unicycive Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Unicycive Therapeutics Inc'in net loss $-37'dir.

Question 5

Unicycive Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Unicycive Therapeutics Inc'in yükümlülüğü 24'dir.

Question 6

Unicycive Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Unicycive Therapeutics Inc'in toplam tedavüldeki hisse sayısı 11.38'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	--	12	8	6	2	1
Research & Development	--	20	12	12	6	1
Operating Expenses	--	32	21	19	8	2
Other Non Operating Income (Expenses)	--	-5	-10	0	0	0
Pretax Income	--	-36	-30	-18	-10	-2
Income Tax Expense	--	--	--	--	--	--
Net Income	--	-37	-31	-18	-10	-2
Net Income Growth	--	19%	72%	80%	400%	0%
Shares Outstanding (Diluted)	--	6.69	2.45	1.5	1.49	1.44
Shares Change (YoY)	--	173%	63%	0%	3%	0%
EPS (Diluted)	--	-5.64	-12.8	-11.99	-6.68	-1.55
EPS Growth	--	-56%	7%	79%	331%	4%
Free Cash Flow	-33	-28	-18	-15	-5	-1
Free Cash Flow Per Share	--	-4.18	-7.33	-9.96	-3.33	-0.68
Gross Margin	--	--	--	--	--	--
Operating Margin	--	0%	0%	0%	0%	0%
Profit Margin	--	0%	0%	0%	0%	0%
Free Cash Flow Margin	--	0%	0%	0%	0%	0%
EBITDA	--	-32	-20	-18	-8	--
EBITDA Margin	--	0%	0%	0%	0%	--
D&A For EBITDA	0	0	0	0	0	--
EBIT	--	-32	-20	-18	-8	-2
EBIT Margin	--	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Unicycive Therapeutics Inc (UNCY) Price

UNCY Stock Price Chart

UNCY Income

Follow-Up Questions